I am wondering as well?
Looks like Mayne Pharma is trying to leverage its well established distribution network.
This is not an earth shattering announcement but another step in the right direction.
Ann: Mayne Pharma adds generic ABSORICA to US portfolio, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.02 |
Change
-0.230(4.38%) |
Mkt cap ! $407.8M | |||
| Open | High | Low | Value | Volume |
| $5.17 | $5.18 | $4.95 | $1.129M | 224.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1227 | $5.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.17 | 1580 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |